Letters, Testimony & Comments

January 9, 2005
BIO's comments on the Proposed Bulletin for Good Guidance Practices released by the Office of Management and Budget (OMB).
January 9, 2005
BIO's comments on the Centers for Medicare and Medicaid Servicesí final rule regarding revisions to the hospital outpatient prospective payment system (OPPS).
January 5, 2005
Docket No. 2004D-0440, Federal Register: October 4th, 2004 (Volume 69, Pages 59239-59240).
December 23, 2004
As posted on CMS's Web site on December 3, 2004
November 20, 2004
Janna Tom, Assistant Director, Office of Technology Transfer, University of California; Vice President for Public Policy, Association of University Technology Managers (AUTM), USA Mission: -Research or Knowledge Generation -Education/Training...
November 16, 2004
To the Members of the U.N. General Assembly: The Biotechnology Industry Organization (BIO) represents more than 1,000 biotechnology companies, academic institutions, state biotechnology centers and related organizations in all 50 U.S. states and...
November 5, 2004
Intervention of BIO Agenda Item 7 Patent Disclosure Requirements relating to Genetic Resources Thank you Mr. Chairman. The Biotechnology Industry Organization (BIO) commends the effort of the Committee to engage in a constructive...
October 26, 2004
October 18, 2004
Dear Sir/Madam: The following comments are provided by the Biotechnology Industry Organization (BIO). BIO represents more than 1,000 biotechnology companies, academic institutions, state biotechnology centers and related organizations in all 50...
October 8, 2004
Relating to CMS' proposed rule revisions from the Federal Register CMS-1427-P, August 16, 2004
October 6, 2004
HEARING ON PROJECT BIOSHIELD II OCTOBER 6, 2004 This statement is submitted by the Biotechnology Industry Organization (BIO), an organization representing over 1,000 companies, universities, research institutions, state biotechnology...
October 4, 2004
Federal Register CMS-4068-P, August 3, 2004